TYRA NASDAQ
Tyra Biosciences, Inc.
1W: +5.6%
1M: -6.2%
3M: -33.9%
YTD: -23.8%
1Y: +44.6%
3Y: +42.9%
5Y: +12.0%
$21.52
+1.10 (+5.39%)
After Hours: $21.28 (-0.24, -1.12%)
Weekly Expected Move ±6.4%
$18
$19
$20
$22
$23
Credit Risk of going bust: lower than 76% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.9%), Tyra Biosciences, Inc. would be worth roughly what it owes.
Total debt $5.6M against a stock market value of $1.22B.
Distance to default 8.81 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.8M (short-term plus half of long-term), stock volatility 67.1%; Altman Z'' 11.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.9%), Tyra Biosciences, Inc. would be worth roughly what it owes.
Total debt $5.6M against a stock market value of $1.22B.
Distance to default 8.81 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.8M (short-term plus half of long-term), stock volatility 67.1%; Altman Z'' 11.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-10-03
Earliest Filing
2022-10-03
Latest Filing
partner: 1
Counterparties (Filed by TYRA)
1 relationshipsCompanies named in TYRA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Virtu Americas LLC | — | partner | Entered into an ATM Sales Agreement to act as sales agent or principal for the sale of up to $150 million in common stoc | 2022-10-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-15 | Other Events; Exhibits | View | |
| 2026-09-09 | Other Events | View | |
| 2026-08-04 | Earnings Release; Exhibits | View | |
| 2026-06-02 | Shareholder Vote | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-04-17 | Officer/Director Change | View | |
| 2026-04-02 | Officer/Director Change | View | |
| 2026-03-04 | Other Events | View | |
| 2026-03-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-01 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-22 | Other Events | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-30 | Other Events | View | |
| 2025-05-29 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-28 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR